Research programme: cGAS/STING antagonists - X-37
Latest Information Update: 28 Oct 2024
At a glance
- Originator X-37
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Nucleotidyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders; Systemic lupus erythematosus
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for research development in Autoimmune-disorders in USA
- 28 Oct 2024 No recent reports of development identified for research development in Systemic-lupus-erythematosus in USA
- 24 Sep 2020 Early research in Autoimmune disorders in USA (unspecified route) (X-37 pipeline, September 2020)